STUDIO
An in-depth look at Ultimovacs’ cancer vaccine
The field of immuno-oncology is growing, and cancer vaccines are a big part of that. Norwegian biotech Ultimovacs is developing its own cancer vaccine technology platform....
RECOMMENDED READING
Rising sales for newly listed Sensidose
Sensidose, active in Parkinson’s disease, reports its best sales figures to date in the...
Promore Pharma’s Q1 characterised by study progress
The reporting season is in full swing and Promore Pharma has now joined the...
